Found: 16
Select item for more details and to access through your institution.
Meningiomas with conspicuous plasma cell-lymphocytic components: a report of five cases.
- Published in:
- 1979
- By:
- Publication type:
- journal article
Partial plasma protein replacement in therapeutic plasma exchange.
- Published in:
- Journal of Clinical Apheresis, 1983, v. 1, n. 2, p. 115, doi. 10.1002/jca.2920010209
- By:
- Publication type:
- Article
Disease-activity-free status in patients with relapsing–remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 4, p. 464, doi. 10.1177/1352458513502113
- By:
- Publication type:
- Article
Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 8, p. 1025, doi. 10.1001/jamaneurol.2014.775
- By:
- Publication type:
- Article
Treatment of natalizumab‐associated PML with filgrastim.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 5, p. 923, doi. 10.1002/acn3.776
- By:
- Publication type:
- Article
Glioblastoma in natalizumab-treated multiple sclerosis patients.
- Published in:
- Annals of Clinical & Translational Neurology, 2017, v. 4, n. 7, p. 512, doi. 10.1002/acn3.428
- By:
- Publication type:
- Article
Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 10, p. 2851, doi. 10.1007/s00415-020-09835-y
- By:
- Publication type:
- Article
(DXT42) Rationale and Design of CLASSIC-MS Study Evaluating Long-Term Efficacy for Patients with Multiple Sclerosis Treated with Cladribine Tablets.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 30
- By:
- Publication type:
- Article
Central Nervous System Expression of Interferon Regulatory Factor 1 Regulates Experimental Autoimmune Encephalomyelitis.
- Published in:
- 2010
- By:
- Publication type:
- Report
Development of somatizing responses in multiple sclerosis.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program.
- Published in:
- Neurology & Therapy, 2016, v. 5, n. 2, p. 169, doi. 10.1007/s40120-016-0048-2
- By:
- Publication type:
- Article
Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 719, doi. 10.1177/13524585231161494
- By:
- Publication type:
- Article
Mechanism of action of 4-aminopyridine in the symptomatic treatment of multiple sclerosis.
- Published in:
- Annals of Neurology, 1995, v. 37, n. 5, p. 684, doi. 10.1002/ana.410370524
- By:
- Publication type:
- Article
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.
- Published in:
- Annals of Neurology, 1990, v. 27, n. 2, p. 186, doi. 10.1002/ana.410270215
- By:
- Publication type:
- Article
Overexpression of the Dominant-Negative Form of Interferon Regulatory Factor 1 in Oligodendrocytes Protects against Experimental Autoimmune Encephalomyelitis.
- Published in:
- Journal of Neuroscience, 2011, v. 31, n. 23, p. 8329, doi. 10.1523/JNEUROSCI.1028-11.2011
- By:
- Publication type:
- Article